Genentech has been instructed to add a boxed warning to its product label for omalizumab (Xolair), which is used to treat patients with asthma related to allergies. The warning emphasizes that this medication may cause anaphylaxis. The FDA has also asked Genentech to revise the label and provide a medication guide for patients to strengthen [...]
The US Food and Drug Administration (FDA) investigates a prescription drug Singulair (Montelukast) used in treating asthma and allergic rhinitis. It intends to reveal a potential link between the drug’s use and changes to behavior and mood, suicide, and suicidal thinking and behavior if it takes place. According to the announcement made on 27th of [...]
It has been proven that taking Singulair tablets once a day help relieve a variety of indoor and outdoor allergy symptoms for up to 24 hours. Gailen Marshall Jr., M.D., Ph.D., director of the Division of Clinical Immunology and Allergy at the University of Mississippi Medical Center in Jackson, MS, considers allergic rhinitis to be [...]
Today it has been known that New York (USA) Pfizer Inc and UCB Pharma confirmed a new chewable formulation of Zyrtec drug (cetirizine HCl). Cetirizine allergy medication is considered to be the number-one prescribed antihistamine by pediatricians and allergists for the treatment of seasonal and perennial allergic rhinitis (inflammation of the nasal passages) and chronic [...]
New data based on Food and Drug Administration investigation into Singulair (Montelukast) don’t confirm a link between this kind of asthma medicine and suicide. This statement is released by Leadership from the American Academy of Allergy Asthma & Immunology and the American College of Allergy, Asthma & Immunology. Besides FDA is confident in lacking of [...]
